🇯🇵 JAPAN • Results & Revisions Daily Roundup - 4th February ▲2371 4502 4739 ▼7741 4452 2317
4TH FEBRUARY ROUNDUP - As expected the 121 Results and 41 Forecast/Revision announcements yesterday took our Results Score 16bps lower to a new...
442 Views
Otsuka Holdings (4578 JP): Voyxact Positive Trial Data Augur Well For the Future
Otsuka presents positive 12-month eGFR data for Voyxact in Phase 3 trial. Regulatory submission likely in 2H26. New drugs like this to drive...
121 Views
JPX Nikkei 400 Rebalance - 2019 Edition Done
The JPX Nikkei 400 Rebalances are, from announcement to end, rarely an interesting event. I was not bullish the Adds vs Deletes performance this...
698 Views
MS-Japan Index Earning Revision (May): Mitsubishi, Takeda Pharmaceutical, Mitsubishi UFJ Financial
We analyzed MS-Japan's consensus for May 2026 and highlighted changes of EPS in Mitsubishi, Takeda Pharmaceutical, Mitsubishi UFJ Financial, Orix,...
134 Views
1k Views